Turn Therapeutics, Inc. (TTRX)
8.06
-0.58
(-6.71%)
USD |
NASDAQ |
Nov 20, 15:51
Turn Therapeutics Debt to Equity Ratio : 1.095 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.095 |
| June 30, 2026 | 8.911 |
| March 31, 2026 | 0.9817 |
| Date | Value |
|---|---|
| December 31, 2025 | 0.014 |
| September 30, 2025 | 0.1638 |
| June 30, 2025 | 0.0419 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Journey Medical Corp. | 0.7945 |
| ANI Pharmaceuticals, Inc. | 0.9531 |
| Corcept Therapeutics, Inc. | 0.0108 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5477 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 16.35M |
| Total Liabilities (Quarterly) | 10.66M |
| Shareholders Equity (Quarterly) | 5.692M |
| Current Ratio | 3.009 |
| Net Debt Paydown Yield | -0.28% |